Neurovascular Devices Market By Size, Status And Forecast 2023Posted by Mangesh on May 22nd, 2019 The Global Neurovascular Devices Market was valued at ,371 million in 2016, and is projected to reach ,409 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. The embolization devices segment held more than two-fifths share of the total market in 2016. Neurovascular devices are used for the treatment of neurovascular disorders such as cerebral aneurysm. Increase in geriatric population and rise in number of patients suffering from neurovascular disorders are expected to drive the market growth. Moreover, surge in adoption of new minimally invasive devices such as flow diversion and carotid artery stents boosts the market growth. However, high cost of the devices and dearth of neurosurgeons are expected to impede the market growth. Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/2278 Asia-Pacific is projected to grow at the highest CAGR of 5.9% during the forecast period owing to improvement in healthcare infrastructures and rise in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs. Technological advancements to develop cost-effective devices in these nations offer a lucrative opportunity for the market growth. The major company profile Are:
Get a purchase enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/2278 Embolization devices segment is expected to dominate the market throughout the analysis period, owing to increase in the incidence of neurovascular disorders, such as arteriovenous malformations (AVMs), carotid artery disease, and intracranial atherosclerotic disease. On the other hand, revascularization devices segment is expected to grow at the highest CAGR of 8.5% during the forecast period. Key Findings of the Neurovascular Devices Market:
Like it? Share it! More by this author |